The increasingly popular class of GLP-1 receptor and GIP co-agonist medications, including tirzepatide, semaglutide, and the newly introduced retatrutide, represent promising advances in the management . https://semaglutide621266.blogmazing.com/42425029/tirzepatide-one-comparative-examination